On Management of Identification and Inspection of Counterfeit and Inferior Drugs from the Perspective of Implementing Drug Administration Law

Zhang Weimin, Huang Qingquan, Liang Jing, Yang Qingyun, Qiao Han, Huang Baobin

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (7) : 727-734.

Chinese Pharmaceutical Affairs ›› 2021, Vol. 35 ›› Issue (7) : 727-734. DOI: 10.16153/j.1002-7777.2021.07.001
Supervision Administration

On Management of Identification and Inspection of Counterfeit and Inferior Drugs from the Perspective of Implementing Drug Administration Law

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2021, 35(7): 727-734 https://doi.org/10.16153/j.1002-7777.2021.07.001

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉